tradingkey.logo
tradingkey.logo
Search

Fulcrum Therapeutics Inc

FULC
Add to Watchlist
3.725USD
-0.005-0.13%
Close 07-28 16:00ETQuotes delayed by 15 min
248.01MMarket Cap
LossP/E TTM

FULC Financials

See Fulcrum Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Fulcrum Therapeutics Inc Earnings Date

Latest Release
Apr 27, 2026
EPS / Forecast
-0.25/-0.30
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
-100.00%
EPS(YoY)
-1.18
-653.29%
Analyst Rating
HOLD
2026/07/28
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
12.28%-0.25
-14.39%-0.31
9.96%-0.31
-131.05%-0.28
34.82%-0.28
32.48%-0.27
10.51%-0.35
331.44%0.89
-4.48%-0.43
20.16%-0.40
---0.39
---0.38
---0.41
---0.50
----
----
----
----
----
----
Revenue
----
--0.00
--0.00
-100.00%0.00
----
-100.00%0.00
-100.00%0.00
8990.91%80.00M
-100.00%0.00
27.15%871.00K
-35.84%759.00K
-53.24%880.00K
-88.62%295.00K
-86.46%685.00K
-76.03%1.18M
-57.04%1.88M
-45.88%2.59M
19.72%5.06M
167.05%4.94M
119.05%4.38M
Net Profit
-7.00%-18.89M
-22.73%-20.33M
9.68%-19.59M
-131.22%-17.30M
34.29%-17.66M
33.07%-16.57M
9.66%-21.70M
332.98%55.41M
-8.44%-26.87M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-11.29%-26.14M
-14.59%-23.74M
-73.40%-34.07M
-52.53%-25.93M
-32.53%-23.48M
-9.25%-20.72M
-25.27%-19.65M
Net Margin
----
----
----
----
----
----
----
102.56%69.26%
----
25.50%-2842.25%
---3164.30%
---2702.61%
---8399.66%
---3815.33%
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
0.00%100.00%
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Revenue
----
--0.00
--0.00
-100.00%0.00
----
-100.00%0.00
-100.00%0.00
8990.91%80.00M
-100.00%0.00
27.15%871.00K
-35.84%759.00K
-53.24%880.00K
-88.62%295.00K
-86.46%685.00K
-76.03%1.18M
-57.04%1.88M
-45.88%2.59M
19.72%5.06M
167.05%4.94M
119.05%4.38M
Operating profit
-10.36%-22.19M
-16.80%-22.69M
5.22%-21.86M
-137.56%-19.71M
32.62%-20.10M
30.59%-19.43M
15.95%-23.06M
292.33%52.49M
-6.78%-29.83M
0.07%-27.99M
-14.86%-27.44M
20.28%-27.29M
-7.47%-27.94M
-18.90%-28.01M
-15.02%-23.89M
-73.94%-34.23M
-52.54%-26.00M
-32.45%-23.56M
-8.72%-20.77M
-23.60%-19.68M
Net Profit
-7.00%-18.89M
-22.73%-20.33M
9.68%-19.59M
-131.22%-17.30M
34.29%-17.66M
33.07%-16.57M
9.66%-21.70M
332.98%55.41M
-8.44%-26.87M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-11.29%-26.14M
-14.59%-23.74M
-73.40%-34.07M
-52.53%-25.93M
-32.53%-23.48M
-9.25%-20.72M
-25.27%-19.65M
Current assets
45.63%338.67M
43.04%357.48M
-23.04%205.86M
-21.73%219.37M
6.70%232.56M
3.19%249.92M
1.90%267.49M
-0.94%280.29M
-28.03%217.95M
16.71%242.20M
15.27%262.49M
62.38%282.95M
51.37%302.83M
-8.18%207.52M
-7.50%227.73M
35.59%174.25M
36.11%200.06M
89.10%226.00M
86.35%246.19M
-4.65%128.51M
Total current liabilities
21.78%9.86M
18.15%13.05M
-19.83%11.63M
-29.25%8.98M
-24.26%8.10M
-19.24%11.04M
3.08%14.51M
-14.22%12.70M
-25.77%10.69M
-18.24%13.68M
-4.25%14.07M
-33.08%14.80M
-21.22%14.41M
-12.89%16.73M
-28.64%14.70M
-1.73%22.12M
-19.19%18.29M
-28.16%19.20M
-22.14%20.60M
61.44%22.51M
Total assets
42.91%346.77M
40.49%366.28M
-22.99%214.86M
-22.23%228.84M
4.33%242.65M
1.17%260.72M
0.05%279.01M
-2.02%294.26M
-27.57%232.59M
13.68%257.69M
12.54%278.88M
53.83%300.33M
45.80%321.12M
-3.54%226.69M
-3.03%247.81M
41.60%195.23M
40.76%220.25M
81.36%235.00M
79.69%255.55M
-4.82%137.88M
Total liabilities
-4.91%13.47M
-2.26%17.28M
-24.06%16.49M
-29.35%14.46M
-25.44%14.16M
-21.41%17.68M
-7.26%21.72M
-17.82%20.47M
-23.60%19.00M
-18.89%22.50M
-11.27%23.42M
-27.77%24.90M
-20.02%24.86M
18.25%27.74M
5.83%26.39M
27.75%34.48M
8.24%31.09M
-31.79%23.46M
-33.02%24.94M
18.73%26.99M
Total equity
45.87%333.30M
43.60%349.00M
-22.90%198.37M
-21.70%214.38M
6.97%228.49M
3.33%243.03M
0.72%257.29M
-0.59%273.79M
-27.90%213.59M
18.22%235.19M
15.38%255.46M
71.33%275.43M
56.62%296.26M
-5.95%198.94M
-3.99%221.41M
44.97%160.75M
48.07%189.16M
122.25%211.54M
119.66%230.61M
-9.20%110.89M
Net operating income
-22.89%-18.75M
-0.22%-16.80M
25.60%-14.19M
-123.46%-13.82M
39.66%-15.26M
27.62%-16.76M
16.74%-19.07M
383.37%58.90M
-4.84%-25.28M
-17.58%-23.16M
17.85%-22.91M
24.05%-20.79M
-9.09%-24.12M
9.89%-19.70M
-23.52%-27.88M
-53.56%-27.37M
-36.24%-22.11M
-10.25%-21.86M
-401.18%-22.57M
-26.20%-17.82M
Net investment
-16400.64%-128.21M
-146.42%-1.05M
327.86%18.61M
211.39%13.93M
-102.04%-777.00K
-87.69%2.26M
-77.13%4.35M
-162.93%-12.51M
140.59%38.13M
150.48%18.35M
934.58%19.02M
-36.69%19.88M
-577.85%-93.94M
-299.85%-36.36M
97.86%-2.28M
219.13%31.39M
58.35%19.66M
37.70%-9.09M
-856.82%-106.64M
-11561.06%-26.35M
Net financing
---312.00K
202673.49%168.30M
-89.92%64.00K
-20.16%301.00K
-100.00%0.00
-71.08%83.00K
--635.00K
165.49%377.00K
-98.60%1.65M
31.65%287.00K
-100.00%0.00
-94.95%142.00K
33719.83%117.69M
-75.53%218.00K
-41.30%80.95M
1244.98%2.81M
-99.27%348.00K
-85.76%891.00K
166248.19%137.90M
-99.68%209.00K

FAQs

What are the current assets of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its current assets were 357.48M, with a year-on-year change of 43.04.

What are the total assets of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its total assets of Fulcrum Therapeutics Inc were 366.28M, with a year-on-year change of 40.49.

What are the total liabilities of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its total liabilities of Fulcrum Therapeutics Inc were 17.28M, with a year-on-year change of -2.26.

What is the total equity of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its total equity of Fulcrum Therapeutics Inc was 349.00M, with a year-on-year change of 43.60.

What is the net operating income of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its net operating income of Fulcrum Therapeutics Inc was -84.37M, with a year-on-year change of -325.38.

What is the net investment of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its net investment of Fulcrum Therapeutics Inc was 30.72M, with a year-on-year change of -4.69.

What is the net financing of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its net financing of Fulcrum Therapeutics Inc was 168.67M, with a year-on-year change of 6042.28.

What is the Earnings Per Share (EPS) of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.18, with a year-on-year change of -653.29.

What is the net income of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its net income was -74.88M, with a year-on-year change of -669.97.

What is the Return on Equity (ROE) of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -25.30, with a year-on-year change of -521.96.

What is the Return on Assets (ROA) of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -23.89, with a year-on-year change of -536.62.

What is the operating profit of Fulcrum Therapeutics Inc?

According to Fulcrum Therapeutics Inc's FY2025 earnings report, its operating profit was -84.37M, with a year-on-year change of -325.38.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.